10 Best Dividend Aristocrat Stocks To Buy Now
Global equity markets are on edge amid uncertainty in the Middle East, compounded by economic growth concerns.
Abbvie Inc. (ABBV)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 9,092,054 | $1,977,430,921 | +1348% | 0.67% |
| 2. | 2,217,000 | $482,175,330 | +10% | 0.08% | |
| 3. | GLG Partners Noam Gottesman | 1,774,415 | $385,917,519 | -2% | 0.7% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 1,470,271 | $319,769,240 | -3% | 0.49% |
| 5. | 1,030,200 | $224,058,198 | -29% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | $106,950.00 | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | $54,000.00 | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | $150,004.80 | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $233.56 | 5,230 | $1,221,518.80 | 2,654 | 2026-03-04 | Filing | |
| $235.26 | 2,600 | $611,676.00 | 4,619 | 2026-03-02 | Filing | |
| $234.66 | 10,291 | $2,414,886.06 | 7,219 | 2026-03-02 | Filing | |
| $233.51 | 5,777 | $1,348,987.27 | 17,510 | 2026-03-02 | Filing | |
| $230.00 | 22,381 | $5,147,630.00 | 38,137 | 2026-02-25 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 318,655 | $80,186,309 | 1.23% | |
| 2. | 164,347 | $41,356,279 | 1.07% | |
| 3. | 25,875 | $6,511,177 | 0.46% | |
| 4. | 14,610 | $3,676,461 | 1.73% | |
| 5. | 13,423 | $3,377,764 | 2.33% |
News See All
10 Best July Dividend Stocks to Buy
Dividend stocks have remained a popular choice for investors over the years. They offer the potential for long-term returns while providing a steady stream of income.
AbbVie (ABBV) to Acquire Apogee Therapeutics
AbbVie Inc. (NYSE:ABBV) is one of the top trending US stocks to buy now. AbbVie Inc.
12 Most Profitable S&P 500 Stocks to Invest In
Profitability is being watched more closely as investors look beyond headline earnings and ask how efficiently companies turn shareholder capital into profits.
10 Trending US Stocks to Buy Now
On June 18, Tom Lee, Fundstrat's Managing Partner and Head of Research, appeared on CNBC's ‘Closing Bell’ to discuss where stocks are headed from Thursday’s levels.
Top 10 Blue Chip Stocks with Growing Dividends
Dividend stocks have also trailed the broader market this year. However, the gap has been relatively narrow.
Top 11 Dividend Kings to Buy for Safe Dividend Growth
Dividend Kings have earned a strong following among income investors because they have proven their ability to raise their dividends through different market cycles.
12 High Quality Stocks to Buy for the Long Term
High-quality stocks are getting more attention as investors look for companies that can keep growing earnings without depending only on market momentum.
10 Undervalued Counter Cyclical Stocks to Buy Now
Counter-cyclical stocks are getting more attention as investors look for businesses tied to demand that does not disappear just because the economy slows.
Is AbbVie Inc. (ABBV) A Good Stock To Buy Now?
Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ABBV.
Hedge Fund Resource Center